Tradestie Institutional Equity Comparison Engine

MESO vs KURA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MESO Overall Edge

MESO Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mesoblast Limited American Depositary Shares (MESO) driven by superior Growth & Margin, Momentum & Technical while KURA counters with relative strength in Options & Structure. Fundamentally, MESO trades at N/M Forward P/E with -42.6% operating margin (+390.7% YoY revenue) versus KURA at N/M Forward P/E and -394.3% operating margin (+10.1% YoY). In options structure, MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro) against KURA sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MESO N/M vs KURA N/M Fwd P/E
Growth & Margin Winner MESO
Op Margin -42.6% vs -394.3% ยท YoY +390.7% vs +10.1%
Momentum & Technical Winner MESO
1Y -16.4% vs -31.6% ยท 52W Pos 6% vs 8%
Options & Structure Winner KURA
UNCLASSIFIED (37th %ile IV) vs BREAKDOWN (20th %ile IV)
MESO NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap $1.7B
1M Return -6.1%
1Y Return -16.42%
Forward P/E N/M
Unified AI Score
34.6 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 50.0
KURA NASDAQ
Kura Oncology, Inc.
Pharmaceutical Preparations
$7.30
-6.05% 1D
Market Cap $690.9M
1M Return -19.6%
1Y Return -31.65%
Forward P/E N/M
Unified AI Score
64.1 / 100 BUY
Tech 63.0 Fund 64.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MESO -16.42% KURA -31.65% Spread: +15.23 pp (MESO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MESO TTM Op. Margin: -42.6% KURA TTM Op. Margin: -394.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MESO vs KURA. Trailing 12-month operating profitability (MESO -42.6% vs KURA -394.3%) and valuation multiples (MESO N/M vs KURA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MESO (5) vs KURA (3)
Institutional Metric MESO KURA Criterion Row Winner
Market Capitalization Scale $1.7B $690.9M Larger Scale MESO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +390.7% +10.1% Higher Growth MESO
Operating Margin (TTM) Profitability -42.6% -394.3% Higher Margin MESO
Net Profit Margin Profitability -47.8% 0.0% Higher Margin KURA
Return on Equity (ROE) Capital Efficiency -9.9% -224.8% Higher ROE MESO
52-Week Range Position Momentum 6% ($12โ€“$22) 8% ($7โ€“$14) Stronger Trend KURA
Beta / 30D Volatility Risk Regime 1.18ฮฒ ยท 78% Vol 1.42ฮฒ ยท 108% Vol Lower Realized Risk MESO
Unified Institutional Score Composite Signal 34.6 / 100 (SELL) 64.1 / 100 (BUY) Higher Composite KURA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MESO vs KURA Buy Guide
MESO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MESO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KURA BREAKDOWN
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 20th %ile
IV Regime Compressed (<25th %ile)
Live KURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MESO nor KURA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.